Advertisement

x

Mathews Journal of Immunology & Allergy

2575-9523

FAQ's


Q: What are the Open Access Journals are available in your Publishing group?
Ans: Please visit the mentioned link [email protected] to view the list of Journals that are available with us.


Q: How can I submit my paper?
The candidate can submit Manuscript in email to [email protected] or submit from the Journal Web page


Q: What is the time required to publish my paper?
Ans: The peer process will take a minimum of 30 business days. After peer revise process, it will be published within 3 days after acceptance of the paper.


Q: How can I join as Reviewer to this Journal?
Ans: You can write your interest in email to [email protected] and we will get back to you in 3-4 days.
 

Q: Do Editor have to work continuously?
Ans: No, the editorial office will be helping you whenever required as we understand that you may be busy in other commitments.


Q: Whom do I have to contact at the Editorial office if I have any queries?
Ans: Kindly email your query to [email protected]. Editorial office or the respective Journal Managing Editor will respond you in 3-4 days.


Q: What is the eligibility if I would like to review a manuscript?
Ans: The reviewers are assigned by the Editors as per the research matching to the topic of manuscript. Self registered peer reviewers must be having a few published papers in the field of interest they mentioned. 


Q: Do you charge for a manuscript submission?
Ans: There are no charges for manuscript submission. The authors only need to pay the article processing charges once the article is accepted.
 
Q: Is there any limit to review papers?
Ans: No. You may review as many manuscripts you wish according to manuscript topic match your interest.


Q: Why should an author pay the article processing charge?
In Open Access mode of publication, the scholarly literature will be made available to the researchers free of cost without any subscription charges. The whole maintenance of the operations i.e production of full text and PDF formats as well as archiving and indexing the published articles permanently through the article processing charges only. However, fee discounts will be provided to the authors from low income countries (According to World Bank classification).

Recently Published Articles
Research Article

Vaccines Against COVID-19 Effectively Prevent the Disease

Published : 05th June 2024
Author : Siniša Franjić*
Citation : Franjić S. (2023). Vaccines Against COVID-19 Effectively Prevent the Disease. Mathews J Immunol Allergy. 8(1):28.

Research Article

Modelizations in 3D of the Anti-HRP Sea Star (or Starfish) Primitive Antibody (IPA): Their Relations with Mus Musculus Fab and In A General Way Mammal Antibodies

Published : 03rd June 2024
Author : Michel Leclerc*
Citation : Leclerc M. (2023). Modelizations in 3D of the Anti-HRP Sea Star (or Starfish) Primitive Antibody (IPA): Their Relations with Mus Musculus Fab and In A General Way Mammal Antibodies. Mathews J Immunol Allergy. 8(1):27.

Research Article

The Sea Star Anti-HRP Protein (IPA: Production in a CHO Protocol, Its Specificity in ELISA. Presence of CDR1 and CDR2 Regions. Aspects of Invertebrate Primitive Antibody

Published : 29th May 2024
Author : Michel Leclerc*
Citation : Leclerc M. (2023). The Sea Star Anti-HRP Protein (IPA: Production in a CHO Protocol, Its Specificity in ELISA. Presence of CDR1 and CDR2 Regions. Aspects of Invertebrate Primitive Antibody. Mathews J Immunol Allergy. 8(1):26.

Research Article

Determination of the CDR (CDR1, CDR2) Complementary-Determining Region Invertebrate Primitive Antibody from Sea Star

Published : 24th February 2024
Author : Michel Leclerc*
Citation : Leclerc M. (2024). Determination of the CDR (CDR1, CDR2) Complementary-Determining Region Invertebrate Primitive Antibody from Sea Star. Mathews J Immunol Allergy. 8(1):25.

Opinion Article

Addressing Lifestyle Disease-Ask WHY

Published : 09th December 2023
Author : Skip Stein*
Citation : Stein S. (2023). Addressing Lifestyle Disease-Ask WHY. Mathews J Immunol Allergy. 7(2):22.

Short Communication

The Sea Star IGKappa Cloning by the Use of E.Coli and CHO Protocol: A New Production of Young Protein

Published : 08th December 2023
Author : Michel Leclerc*
Citation : Leclerc M. (2023). The Sea Star IGKappa Cloning by the Use of E.Coli and CHO Protocol: A New Production of Young Protein. Mathews J Immunol Allergy. 7(2):23.

Indexed
Root Indexing
WolrdCat
J Gate
Directory of Research Journals Indexing
International Scientific Indexing
Genamics JournalSeek
Scientific Indexing Services
International Committee of Medical Journal Editors
Scilit
CiteFactor
Google Scholar
Subscribe

Subscribe to our RSS feed, be in touch with our articles, news, videos, reebies.

Antispam Code Generate new code

Creative Commons License

© 2015 Mathews Open Access Journals. All Rights Reserved.

Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at Mathewsopenaccess.com